Ankyra Therapeutics, Inc.
Clinical trials sponsored by Ankyra Therapeutics, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New injection targets Hard-to-Treat cancers Results expected Apr 2027 (estimated)
- New combo therapy aims to boost immune response in hard-to-treat lung cancer Results expected Jun 2027 (estimated)